Geetha, Duvuru http://orcid.org/0000-0001-8353-5542
Kronbichler, Andreas http://orcid.org/0000-0002-2945-2946
Rutter, Megan
Bajpai, Divya
Menez, Steven http://orcid.org/0000-0003-2490-025X
Weissenbacher, Annemarie
Anand, Shuchi
Lin, Eugene
Carlson, Nicholas
Sozio, Stephen
Fowler, Kevin
Bignall, Ray
Ducharlet, Kathryn
Tannor, Elliot K.
Wijewickrama, Eranga
Hafidz, Muhammad I. A.
Tesar, Vladimir
Hoover, Robert
Crews, Deidra
Varnell, Charles
Danziger-Isakov, Lara
Jha, Vivekanand http://orcid.org/0000-0002-8015-9470
Mohan, Sumit
Parikh, Chirag http://orcid.org/0000-0001-9051-7385
Luyckx, Valerie
Article History
Accepted: 29 July 2022
First Online: 24 August 2022
Change Date: 20 September 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41581-022-00635-3
Competing interests
: D.G. is a consultant to ChemoCentryx, Aurinia Inc and GSK, and received support from the Johns Hopkins Center for Innovative Medicine. A.K. is a consultant to Vifor, Otsuka, Delta4, Catalyst Biosciences and UriSalt, and received funding from Vifor and Otsuka. M.R. is funded by a Versus Arthritis Clinical Research Fellowship. S.A. has a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK127138); Ascend Clinical Laboratory funded sample testing for S.A.’s work on SARS-CoV-2 seroepidemiology among patients on dialysis. E.L. received a consulting fee from Acumen, LLC, a federal contractor, and funding from National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (K08 DK118213) and from the University Kidney Research Organization. V.T. is a consultant for AbbVie, Amgen, Baxter, Bayer, Boehringer Ingelheim, Calliditas, ChemoCentryx and Fresenius Medical Care, Omeros and Travere. V.T. is also a speaker for Bayer and Boehringer Ingelheim, and received travel expenses from AbbVie. D.C. was supported by grant 1 K24 HL148181 from the National Heart, Lung and Blood Institute, National Institutes of Health (NIH), and received research grant funding from Somatus Medical, Inc. and Baxter International, for unrelated work. N.C. received lecture fees Bristol Myers Squibb, and funding from The Danish Heart Foundation. V.J. received grant funding from GSK, Baxter Healthcare and Biocon, and honoraria from Bayer, AstraZeneca, Boehringer Ingelheim, NephroPlus and Zydus Cadilla, under the policy of all monies being paid to the organization. S.M. received grants from the NIH (DK126739, DK114893, DK130058, MD014161, DK116066) and the Kidney Transplant collaborative as well as personal fees from Kidney International Reports and HSAG, outside the submitted work. C.P. is a member of the advisory board of and owns equity in RenalytixAI, serves as a consultant for Genfit and Novartis, and is supported by NIH grants R01HL085757, UH3DK114866, U01DK106962 and R01DK093770. V.L. received funding from the Swiss Kidney Foundation. All other authors declare no competing interests.
Free to read: This content has been made available to all.